2012
DOI: 10.1016/j.mce.2012.08.003
|View full text |Cite
|
Sign up to set email alerts
|

The molecular mechanisms of pancreatic β-cell glucotoxicity: Recent findings and future research directions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
243
0
7

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 252 publications
(253 citation statements)
references
References 476 publications
3
243
0
7
Order By: Relevance
“…1,18,27). In this study, acute pharmacological GK activation increased the glucose sensitivity of control islets but failed at restoring ␤-cell glucose responsiveness in rat islets cultured for 1 wk at nonstimulating or very high vs. intermediate glucose concentration.…”
Section: Discussionmentioning
confidence: 59%
See 3 more Smart Citations
“…1,18,27). In this study, acute pharmacological GK activation increased the glucose sensitivity of control islets but failed at restoring ␤-cell glucose responsiveness in rat islets cultured for 1 wk at nonstimulating or very high vs. intermediate glucose concentration.…”
Section: Discussionmentioning
confidence: 59%
“…This possible caveat of GKAs has been previously considered nonrelevant on the ground that ␤-cell stimulation is reduced following the GKA-mediated reduction in glycemia (12). However, given the metabolic heterogeneity of ␤-cells in rodent islets (37), the present study suggests that GKAs may be beneficial in poorly responsive ␤-cells while being simultaneously toxic to middle-and highly-responsive ␤-cells through a variety of mechanisms proposed to contribute to glucotoxicity (1). If such "glucotoxic-like" effects of long-term GKA treatment at intermediate glucose concentration were confirmed in human islets, it could contribute to the secondary failure of GKAs in T2D (22,31,47).…”
Section: E636mentioning
confidence: 65%
See 2 more Smart Citations
“…A hiperglicemia e hiperlipidemia por períodos prolongados (glicolipotoxicidade), comuns na obesidade, conduzem à deficiência orgânica das células β pancreáticas, refletida na resistência à insulina autócrina, na expressão diminuída dos genes envolvidos na produção da insulina, na diminuição de células β causada por apoptose e finalmente na secreção inadequada de insulina. Consequentemente, a deficiência de insulina produzida no pâncreas relativa à obesidade é consequência do dano celular e da ineficiência na síntese de insulina, acarretando o desenvolvimento do diabetes tipo 2 (ALEJANDRO et al, 2015;BENSELLAM; LAYBUTT; JONAS, 2012). …”
unclassified